Multitargeted Tyrosine Kinase Inhibition Produces Discordant Changes Between 99mTc-MDP Bone Scans and Other Disease Biomarkers: Analysis of a Phase II Study of Sunitinib for Metastatic Castration-Resistant Prostate Cancer
Saylor, P. J., Mahmood, U., Kunawudhi, A., Smith, M. R., Palmer, E. L., Michaelson, M. D.Volume:
53
Language:
english
Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.112.105007
Date:
November, 2012
File:
PDF, 808 KB
english, 2012